Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Diagnostic Performance of Combined Assays for Gastrin-17, Pepsinogen and Anti-helicobacter Pylori Antibodies for Diagnosing Gastric Atrophy.

NCT07060482 is registered in ClinicalTrials.gov with Royal College of Surgeons, Ireland as lead sponsor.

NCT NCT07060482
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07060482 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Diagnostic Performance of Combined Assays for Gastrin-17, Pepsinogen and Anti-helicobacter Pylori Antibodies for Diagnosing Gastric Atrophy.
Lead sponsor
Royal College of Surgeons, Ireland
Phase
Observational
Overall status
Not yet recruiting
Start date
August 1, 2025
Completion date
February 1, 2026
Enrollment
240 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

gastric atrophy